Auriclotherapy on stress, anxiety and depression after mastectomy

Investigating the effect of auriclotherapy on the level of stress, anxiety and depression after mastectomy in women with breast cancer

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20091219002889N13

Enrollment

Registered

2022-11-07

Start date

2022-10-26

Completion date

Unknown

Last updated

2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stress, anxiety and depression. Reaction to severe stress, and adjustment disorders

Interventions

Intervention group: They undergo ten weekly sessions of auriclotherapy (Relax, Mr. Shoulder, Long 2, Anxiety, Shen Man and Thalamic points) and then Vaccaria seeds is placed on the corresponding point

Eligibility

Sex/Gender

Female

Age

15 Years to 54 Years

Inclusion criteria

Inclusion criteria: Iranian nationality At least two weeks have passed since the mastectomy Reproductive age Obtaining a score of at least 19 in the DASS questionnaire before intervention

Exclusion criteria

Exclusion criteria: Not suffering from infectious diseases and other neurological diseases such as MS Absence of infection and apparent abnormality in the ear Non-use of complementary medicine techniques during the last two months

Design outcomes

Primary

Measure	Time frame
Score of stress, anxiety and depression in DASS questionnaire. Timepoint: Before and after intervention. Method of measurement: The depression anxiety stress scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahboubeh Valiani

Esfahan University of Medical Sciences

valiani@nm.mui.ac.ir+98 31 3668 7153

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026